All
Top 5 Articles of the Week: March 23-28
Explore the top headlines of the week including insights on clinical trials, CBD products, and more.
Dermatology Times' Sunday Crossword: March 30, 2025
Test your knowledge of key words and terms associated with dermatology news from the previous week.
The Weekly Roundup: March 24-28
In case you missed it, this week we had news about CBD products in dermatology, Journey Medical's launch of Emrosi for rosacea, the psychological impact of melanoma, and more.
The Rx Recap: March 23-29
This week, we feature top articles from our sister publications on clinical trials, FDA updates, and more.
Daily Derm Times: March 28, 2025
Catch up on dermatology news, highlights, and insights from the past 24 hours.
Dermatology Times March 2025 Print Recap
Learn more about the in-depth topics covered in the March 2025 print issue of Dermatology Times.
Review and Meta-Analysis Compares Delgocitinib to Vehicle for Chronic Hand Eczema Treatment
Patients with CHE saw higher treatment success and a favorable safety profile with delgocitinib 20-30 mg/g.
Top 5 Articles of the Month: March
Explore the top headlines of the week including insights on recalls, expert pearls, and more.
Undersleeping is a Potential Risk Factor for Cutaneous Melanoma
Two-sample Mendelian randomization analysis explored lifestyle factors such as sleep, smoking, alcohol consumption, and sedentary behavior.
Machine Learning Enhances Laser Treatment Planning
With an increasing demand for laser procedures, AI-based skin assessments may help ensure safer and more effective treatments.
Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis
The therapy, which combines clindamycin phosphate, adapalene, and benzoyl peroxide, was effective for Hispanic patients with moderate to severe lesions.
Dermatology Times March 2025 Recap
Dermatology Times is looking back on the top stories in dermatology from the month of March.
Daily Derm Times: March 27, 2025
Topical Xyngari Meets All Primary Endpoints in Phase 3 Study for Moderate to Severe Acne
Xyngari showed promise as the first once-weekly topical acne treatment, achieving strong phase 3 results with significant efficacy and safety.
Can BSZY Cream Reduce Symptoms of Facial Atopic Dermatitis?
The cream contains barrier-repairing ingredients that may enhance self-healing and hydration in affected skin.
Novel Synthesized Silver Nanoparticle Shampoo is Comparable to 2% Ketoconazole for SD Treatment
In a prospective study, patients with scalp seborrheic dermatitis saw positive results in efficacy, safety, and quality of life when using the AgNP product.
Patient and Physician Perspectives Assess Long-Term Impact of Tildrakizumab for Psoriasis
Treatment with tildrakizumab was still safe and effective after 1 year with notable improvements in patients’ quality of life.
Understanding the Psychological Impact of Melanoma
Nearly half of patients with melanoma experience significant distress, affecting treatment adherence and quality of life.
Interview Intersection: Expert Interviews From March 2025
Dermatology Times is recapping our exclusive expert interviews from the month of March.
Daily Derm Times: March 26, 2025
CBD and CBG Ointment Improved Skin in Patients with Atopic Dermatitis
Use of the product showed positive changes in the skin’s hydration, lipid content, transepidermal water loss, and erythema.
Active Education Outperforms Passive Approaches in Melanoma Detection by Non-Medical Individuals
A study shows active educational interventions improve melanoma detection rates and rule application, with lasting effects over time.
An Up-to-Date Review of Rosacea in Childhood and Adolescence
Researchers behind a recent review shared expert insights, treatment guidelines, and differential diagnosis techniques for pediatric rosacea.
Novel Moisturizing Formulation is Effective for Repairing Skin After Microneedling
When compared to a non-active product, the formula improved texture, reduced erythema, and strengthened the skin barrier.
Unraveling Type 2 Inflammation in Skin Diseases
Targeting type 2 cytokines with monoclonal antibodies has revolutionized treatment for inflammatory skin diseases, reducing symptoms and improving quality of life.
Journal Digest: March 26
This review of the latest dermatologic studies includes insights into atopic dermatitis, including results from a novel topical CBD application, skin mycobiome comparison, and more.
Daily Derm Times: March 25, 2025
Expert Recommendations for Personalized AD Treatment
An expert panel of clinicians provided insights on first-line treatments, maintenance strategies, and flare management for AD.
Quoin Files US Patent Applications for Rare Disease Treatments
The novel treatments will be for patients with orphan conditions like Netherton Syndrome, Peeling Skin Syndrome, SAM Syndrome, and palmoplantar keratoderma.
Biologics Targeting IL-12, IL-23, and IL-17 Reduce Serious Infections in Older Adults with Psoriatic Disease
A study reveals that biologics targeting IL-12, IL-23, and IL-17 lower the risk of serious infections in older adults with psoriatic disease.